Get started
Author

Takuto Mori

Germ line DDX41 mutations define a unique subtype of myeloid neoplasms
2022 · Hideki Makishima, Ryunosuke Saiki, et al. · Blood · 162
Application of long-distance polymerase chain reaction to detection of junctional sequences created by chromosomal translocation in mature B- cell neoplasms
1996 · T Akasaka, M Muramatsu, et al. · Blood · 66
PDF
Somatic PHF6 mutations in 1760 cases with various myeloid neoplasms
2016 · T Mori, Y Nagata, et al. · Leukemia · 45
Amplified EPOR / JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia
2022 · June Takeda, Kenichi Yoshida, et al. · Blood Cancer Discovery · 27
PDF
Coincidence of cutaneous blastic plasmacytoid dendritic cell neoplasm and myelodysplastic syndrome derived from clonal hematopoiesis
2023 · Tomohiko Yamada, Nobuhiro Hiramoto, et al. · Blood Cancer Journal · 6
PDF
CTX-712, a Novel Splicing Modulator Targeting Myeloid Neoplasms
2022 · Akinori Yoda, Daisuke Morishita, et al. · Blood · 5
Coexistence of HLA and KIR ligand mismatches as a risk factor for viral infection early after cord blood transplantation
2022 · Tomoki Iemura, Yasuyuki Arai, et al. · Bone Marrow Transplantation · 3
[Roles of department of laboratory medicine on the new patient clinic].
1993 · T Mori · PubMed · 2
Risk Factors for and Impact of Pre‐Engraftment Syndrome on Outcomes Following Single‐Unit Cord Blood Transplantation in Adults
2025 · Masatoshi Sakurai, Keisuke Kataoka, et al. · American Journal of Hematology · 1
PDF
Abstract 5494: CTX-712, a novel splicing modulator targeting myeloid neoplasms
2022 · Akinori Yoda, Daisuke Morishita, et al. · Cancer Research · 1
Mycophenolate mofetil-based graft-versus-host disease prophylaxis is associated with an increased risk of human herpesvirus 6B encephalitis after cord blood transplantation
2026 · Takuto Mori, Nobuhiro Hiramoto, et al. · Bone Marrow Transplantation
Abstract 5932: Cell free DNA based genomic analysis revealed the distinct whole genome landscape and chronology of intravascular large B cell lymphoma
2026 · Takuto Mori, Kazuyuki Shimada, et al. · Cancer Research
Cohesin constrains histone modification-driven chromatin dynamics
2025 · Takeshi Fujino, Yotaro Ochi, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Whole-genome analysis reveals shared early genetic alterations and subtype-specific immune evasion pathways in intravascular large B-cell lymphoma and immune-privileged large B-cell lymphoma
2025 · Takuto Mori, Kazuyuki Shimada, et al. · Blood
Whole-Genome Analysis Revealed the Genetic Landscape of Intravascular Large B-Cell Lymphoma
2024 · Takuto Mori, Kazuyuki Shimada, et al. · Blood
Abstract 2081: Biomarkers for CLK inhibitor CTX-712 treatment response in myeloid neoplasms: Paving the way toward clinical trials
2024 · Akinori Yoda, Daisuke Morishita, et al. · Cancer Research
Data from Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia
2023 · June Takeda, Kenichi Yoshida, et al.
Data from Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia
2023 · June Takeda, Kenichi Yoshida, et al.
Supplementary Table from Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia
2023 · June Takeda, Kenichi Yoshida, et al.
Supplementary Figure from Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia
2023 · June Takeda, Kenichi Yoshida, et al.
Supplementary Table from Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia
2023 · June Takeda, Kenichi Yoshida, et al.
Supplementary Figure from Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia
2023 · June Takeda, Kenichi Yoshida, et al.
Epitope Mismatch at HLA-DRB1 Associates with Reduced Relapse Risk in Cord Blood Transplantation for Standard-Risk Hematologic Malignancy
2023 · Mari Morita-Fujita, Takero Shindo, et al. · Transplantation and Cellular Therapy
Cooperative Effects of SRSF2 and STAG2 mutations on Development of Myelodysplastic Syndrome and Its Related Disorders
2022 · Takuto Mori, Yotaro Ochi, et al. · Blood
Germline Risks and Clinical Impacts of DDX41 Mutations in Myeloid Malignancies
2022 · Hideki Makishima, Ryunosuke Saiki, et al. · Blood
Works count: 30
Citation count: 318
H-index: 5
I10-index: 4
Year
Topic
Type